Literature DB >> 15130999

Histamine H4 antagonism: a therapy for chronic allergy?

Bruce L Daugherty1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15130999      PMCID: PMC1574922          DOI: 10.1038/sj.bjp.0705730

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  13 in total

1.  The first potent and selective non-imidazole human histamine H4 receptor antagonists.

Authors:  Jill A Jablonowski; Cheryl A Grice; Wenying Chai; Curt A Dvorak; Jennifer D Venable; Annette K Kwok; Kiev S Ly; Jianmei Wei; Sherry M Baker; Pragnya J Desai; Wen Jiang; Sandy J Wilson; Robin L Thurmond; Lars Karlsson; James P Edwards; Timothy W Lovenberg; Nicholas I Carruthers
Journal:  J Med Chem       Date:  2003-09-11       Impact factor: 7.446

Review 2.  Eosinophilia.

Authors:  M E Rothenberg
Journal:  N Engl J Med       Date:  1998-05-28       Impact factor: 91.245

3.  Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells.

Authors:  Claudia L Hofstra; Pragnya J Desai; Robin L Thurmond; Wai-Ping Fung-Leung
Journal:  J Pharmacol Exp Ther       Date:  2003-03-06       Impact factor: 4.030

4.  Cloning and characterization of a novel human histamine receptor.

Authors:  K L Morse; J Behan; T M Laz; R E West; S A Greenfeder; J C Anthes; S Umland; Y Wan; R W Hipkin; W Gonsiorek; N Shin; E L Gustafson; X Qiao; S Wang; J A Hedrick; J Greene; M Bayne; F J Monsma
Journal:  J Pharmacol Exp Ther       Date:  2001-03       Impact factor: 4.030

5.  Discovery of a novel member of the histamine receptor family.

Authors:  T Nguyen; D A Shapiro; S R George; V Setola; D K Lee; R Cheng; L Rauser; S P Lee; K R Lynch; B L Roth; B F O'Dowd
Journal:  Mol Pharmacol       Date:  2001-03       Impact factor: 4.436

6.  Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation.

Authors:  Ping Ling; Karen Ngo; Steven Nguyen; Robin L Thurmond; James P Edwards; Lars Karlsson; Wai-Ping Fung-Leung
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

Review 7.  Histamine: A mediator of inflammation.

Authors:  Donald MacGlashan
Journal:  J Allergy Clin Immunol       Date:  2003-10       Impact factor: 10.793

8.  Histamine induces cytoskeletal changes in human eosinophils via the H(4) receptor.

Authors:  Karen F Buckland; Timothy J Williams; Dolores M Conroy
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

9.  Identification of a histamine H4 receptor on human eosinophils--role in eosinophil chemotaxis.

Authors:  Mark O'Reilly; Robbin Alpert; Stephen Jenkinson; Ronald P Gladue; Shane Foo; Steven Trim; Beate Peter; Mike Trevethick; Mark Fidock
Journal:  J Recept Signal Transduct Res       Date:  2002 Feb-Nov       Impact factor: 2.092

10.  Pharmacologic characterization of a novel histamine receptor on human eosinophils.

Authors:  D G Raible; T Lenahan; Y Fayvilevich; R Kosinski; E S Schulman
Journal:  Am J Respir Crit Care Med       Date:  1994-06       Impact factor: 21.405

View more
  3 in total

Review 1.  The role of histamine H4 receptor in immune and inflammatory disorders.

Authors:  E Zampeli; E Tiligada
Journal:  Br J Pharmacol       Date:  2009-03-20       Impact factor: 8.739

2.  In vitro and in vivo characterization of A-940894: a potent histamine H4 receptor antagonist with anti-inflammatory properties.

Authors:  M I Strakhova; C A Cuff; A M Manelli; T L Carr; D G Witte; J L Baranowski; T A Vortherms; T R Miller; L Rundell; M J McPherson; R M Adair; A A Brito; B M Bettencourt; B B Yao; J M Wetter; K C Marsh; H Liu; M D Cowart; J D Brioni; T A Esbenshade
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

3.  Histamine activates inflammatory response and depresses casein synthesis in mammary gland of dairy cows during SARA.

Authors:  Guangjun Chang; Lailai Wang; Nana Ma; Wenwen Zhang; Huanmin Zhang; Hongyu Dai; Xiangzhen Shen
Journal:  BMC Vet Res       Date:  2018-05-23       Impact factor: 2.741

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.